Which bank will first address stimulant use among employees by December 31, 2025?
Goldman Sachs • 25%
JP Morgan • 25%
Morgan Stanley • 25%
Other • 25%
Official statements or press releases from the banks
Over 50 Wall Street Bankers Use Adderall and Vyvanse to Cope with 100-Hour Work Weeks at More Than a Dozen Banks
Dec 15, 2024, 02:14 AM
A recent report highlights that many Wall Street bankers rely on stimulants such as Adderall and Vyvanse to manage the demands of their high-pressure jobs. Interviews conducted with over 50 current and former investment bankers across more than a dozen firms reveal that the use of these drugs is openly discussed and prevalent in the workplace. The report emphasizes the extreme work hours, with some bankers reportedly working over 100 hours a week, leading to a reliance on increasing doses of Adderall and other substances to maintain productivity. A medical professional noted that there is a limit to human productivity, indicating the strain these long hours place on workers.
View original story
Goldman Sachs • 25%
JPMorgan Chase • 25%
Morgan Stanley • 25%
Other • 25%
Yes • 50%
No • 50%
SEC • 25%
FDA • 25%
FINRA • 25%
Other • 25%
Other • 25%
Morgan Stanley • 25%
Goldman Sachs • 25%
JPMorgan Chase • 25%
Other major bank • 25%
Wells Fargo • 25%
Bank of America • 25%
JPMorgan Chase • 25%
JPMorgan Chase • 25%
Other • 25%
Citigroup • 25%
Goldman Sachs • 25%
None of the above • 25%
Bank of America • 25%
JPMorgan Chase • 25%
Wells Fargo • 25%
Raytheon Australia • 25%
Hudson Technologies Co. • 25%
Raytheon Canada • 25%
Insitu Inc. • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Public relations • 25%
Employee well-being • 25%
Other • 25%
Regulatory pressure • 25%